As a consequence, stabilized OCT1 contributed to ALDH1A1 upregulation and enhanced cancer stemness, implying the therapeutic potential of targeting serial ubiquitination in patients with CRC [55]. This evidence concerns the gene ALDH1A1 and cancer.